HIV/AIDS News Alert!

Adult and Adolescent Opportunistic Infections
Guidelines Updated

July 28, 2017: The following sections of the Guidlines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents have recently been updated:
Click here to view recently updated guidlines

Sections of the Pneumocystis guidlines have been updated to modernize some of the language and to more closely reflect the standard of care in 2017, which includes early cART initiation for all patients. In addition, suggested criteris for stopping both primary and secondary prophylaxis in patients with HIV viral loads below detection limits and CD4 counts between 100 and 200 cells/mm3 are provided.
Click here to view Pneumocystis Pneumonia guidlines

Sections of the toxoplasmosis guidlines have been updated to modernize some of the language and to more closely reflect the standard of care in 2017, which includes early cART initiation for all patients. Greater detail is provided on the management of toxoplasmosis during pregnancy. In addition, suggested criteria for stopping primary prophylaxis in patients with HIV viral loads below detection limits and CD4 counts between 100 and 200 cells/mm3 are provided.
Click here to view Toxoplasmosis gondii Encephalitis
Click to view Table 1
Click to view Table 2
Click here to view Table 4

Drug Interaction Concerns May Negatively Affect HIV Treatment Adherence Among Transgender Women
New findings at the 9th International AIDS Society Conference on HIV Science in Paris.

July 24, 2017: Transgender women-people whose birth certificates indicate or once indicated male sex but who identify as women-are at high risk of HIV acquisition, and thus are a key population for HIV prevention and treatment efforts. A new study by researchers supported by the National Institutes of Health and Gilead Sciences reveals that among transgender women in Los Angeles, more than half of those living with HIV were concerned that taking both antiretroviral therapy (ART) for the treatment of HIV and feminizing hormone therapy (HT) may be associated with harmful drug interaction, about which little is clinically understood. Many in the surveyed group cited these concerns as a reason for not taking anti-HIV medications, HT, or both as prescribed by a health care professional.

Click here to read the full press release

Good News! More people living with HIV have the virus under control.

"Half of Americans with HIV now have the virus under control", said Jonathan Mermin, M.D.,M.P.H.,director of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. "We can't stop halfway - we can test, treat, and defeat HIV."

Of the estimated 1.1 million people living with HIV in the United States, 85 percent were diagnosed and knew they had HIV, and 49 percent had the virus under control through HIV treatment, according to new CDC estimates based on the most recent national data from 2014. CDC previously estimated that in 2010, 28 percent of people living with HIV in America had the virus under control.

Click here to read the full press release